Grant of Options
Source: RNS
05 August 2024
CAMBRIDGE NUTRITIONAL SCIENCES PLC
("CNSL" or the "Company")
Grant of Options
CNSL, (AIM:CNSL) the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 05 August 2024 the Board granted share options (the "Options") over its ordinary shares of 4.0 pence each ("Ordinary Shares") to James Cooper, Chief Operating Officer and Executive Director.
Following this grant of Options, the Company has options in issue over 20,184,049 Ordinary Shares, representing approximately 8% per cent. of the Company's total issued share capital.
|
Director |
Number of Options granted on |
Exercise Price |
Total options held |
|
|
2,000,000 |
4.0p |
2,000,000 |
Grant of Options
The Company has granted the Options to incentivise executive director performance for the benefit of all Shareholders.
The Options are subject to time conditions (as set out below); good/bad leaver provisions; and being a director of the Company on the date of vesting.
Vesting criteria for Options are subject to time conditions as follows:
|
Amount Vesting |
Time Condition |
|
34 per cent. ("Tranche One") |
On the first anniversary of 5 August 2024 |
|
33 per cent. ("Tranche Two") |
On the second anniversary of 5 August 2024 |
|
33 per cent. ("Tranche Three") |
On the third anniversary of 5 August 2024 |
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).
For further information, please contact:
|
Cambridge Nutritional Sciences Plc Jag Grewal, Chief Executive Officer
|
investors@cnsplc.com |
|
Cavendish Capital Markets Limited Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) Nigel Birks / Harriet Ward (ECM) |
Tel: 020 7220 0500 |
About Cambridge Nutritional Sciences Plc
Cambridge Nutritional Sciences Plc (AIM: CNSL) is the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
a) |
Name |
James Cooper |
||||
|
2. |
Reason for the notification |
|||||
|
a) |
Position/status |
Chief Operating Officer, Executive Director |
||||
|
b) |
Initial notification/ |
Initial Notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Cambridge Nutritional Sciences plc |
||||
|
b) |
LEI |
2138007U9P4BTZTYIR92 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the |
Options over Ordinary Shares of 4.0p each |
||||
|
Identification code |
ISIN: GB00B1VCP282 |
|||||
|
b) |
Nature of |
Grant of Options |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
n/a |
||||
|
e) |
Date of the |
5 August 2024 |
||||
|
f) |
Place of the transactions |
Outside a trading venue |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
